Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19

Detalles Bibliográficos
Autores principales: Vorobjeva, Nina V., Sud'ina, Galina F., Chernyak, Boris V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/
https://www.ncbi.nlm.nih.gov/pubmed/33584318
http://dx.doi.org/10.3389/fphar.2021.609508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/
https://www.ncbi.nlm.nih.gov/pubmed/33584318
http://dx.doi.org/10.3389/fphar.2021.609508

Ejemplares similares